IDBA — Stock Film
STOCK FILMSCENE 1/11IDBA · $4.88
Stock Expert AI presents
IDBA
IDEX Biometrics ASA
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
IDEX Biometrics ASA. A quick introduction.

On the stock market since 2021, it operates in the world of technology. It has 79 employees. Now — the numbers.

on the stock market since 2021
79 employees
$90.8M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $7.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are moving sideways.

No real growth (3% a year). Red columns mark years that ended in a loss.

$3.7M
2019
$1.1M
2020
$2.8M
2021
$4.1M
2022
$4.2M
2023
In the vault right now:
$0
DEBT: $7.0M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

Every quarter, analysts set a profit bar.
How many of the last 6 did the company clear?
2 / 6
EXPECTATIONS MET OR BEATEN
2
Aug 2022
Nov 2022
Feb 2023
May 2023
Aug 2023
Nov 2023
2 TIMES IN THE LAST 6 QUARTERS
It misses the bar more often than not.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Heavy investment in the future10/10
WEAK SPOTS
The stock has lost its spark0/10
Each sale is made at a loss3/10
Costs eat into the margin4/10
WORTH WATCHING

Profit per Sale: Right now the product sells for less than it costs to make; every sale deepens the loss.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 84% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 3 years, sales grew about 56% a year on average.

2
THE BRIGHT SIDE · 2/2
The product is selling

Sales run at $4.2M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $26.7M against $4.2M in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, IDBA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: IDBA is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film